Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oridonin Inhibits SARS‐CoV‐2 by Targeting Its 3C‐Like Protease
Baisen Zhong, Weiyu Peng, Shan Du, et al.
Small Science (2022) Vol. 2, Iss. 6
Open Access | Times Cited: 25

Showing 25 citing articles:

The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19
Qing Hu, Yuan Xiong, Guanghao Zhu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 148
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 82
Bioactive natural products in COVID-19 therapy
Zhonglei Wang, Ning Wang, Liyan Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 58
Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy – A comprehensive review
Muhammad Asif Ali, Noohela Khan, Ahmad Ali, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 5, pp. 3046-3067
Open Access | Times Cited: 11
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Yue Yang, Yidan Luo, Chenbo Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34196-34219
Open Access | Times Cited: 6
Portable light-sheet optofluidic microscopy for 3D fluorescence imaging flow cytometry
Jeonghwan Son, Biagio Mandracchia, Aaron D. Silva Trenkle, et al.
Lab on a Chip (2023) Vol. 23, Iss. 4, pp. 624-630
Open Access | Times Cited: 11
Insights into SARS-CoV-2 structure: Approaches and action of SARS-CoV-2 main protease inhibitor
Ilma Shakeel, Aaliya Taiyab, Aanchal Rathi, et al.
Elsevier eBooks (2025), pp. 89-117
Closed Access
Oridonin inhibits SARS-CoV-2 replication by targeting viral proteinase and polymerase
Zherui Zhang, Hongqing Zhang, Yanan Zhang, et al.
Virologica Sinica (2023) Vol. 38, Iss. 3, pp. 470-479
Open Access | Times Cited: 10
Discovery of the covalent SARS‐CoV‐2 Mpro inhibitors from antiviral herbs via integrating target‐based high‐throughput screening and chemoproteomic approaches
Yani Zhang, Guanghao Zhu, Wei Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 11
Closed Access | Times Cited: 10
Harnessing Natural Products by a Pharmacophore‐Oriented Semisynthesis Approach for the Discovery of Potential Anti‐SARS‐CoV‐2 Agents
Yuan‐Fei Zhou, Bing‐Chao Yan, Qian Yang, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 28
Open Access | Times Cited: 15
Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Zhonglei Wang, Xian-qing Song, Wenjing Xu, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 3885-3885
Open Access | Times Cited: 9
Single‐Cell Transcriptomics Reveals the Ameliorative Effect of Oridonin on Septic Liver Injury
Jing Liu, Qian Zhang, Yin Kwan Wong, et al.
Advanced Biology (2024) Vol. 8, Iss. 3
Closed Access | Times Cited: 2
Target discovery of bioactive natural products with native-compound-coupled CNBr-activated Sepharose 4B beads (NCCB): Applications, mechanisms and outlooks
Yueteng Zhang, Junjie Zhang, Menglong Li, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 96, pp. 117483-117483
Closed Access | Times Cited: 4
Application of docking-based inverse high throughput virtual screening to found phytochemical covalent inhibitors of SARS-CoV-2 main protease, NSP12 and NSP16
Yaroslav V. Faletrov, Viktoryia A. Staravoitava, Anastasiya R. Dudko, et al.
Research Square (Research Square) (2022)
Closed Access | Times Cited: 7
The Inhibitory Effects and Cytotoxic Activities of the Stem Extract of Sarracenia purpurea against Melanoma Cells and the SsbA Protein
Hongwen Liu, Wei-Yu Chiang, Yen‐Hua Huang, et al.
Plants (2022) Vol. 11, Iss. 22, pp. 3164-3164
Open Access | Times Cited: 7
Analysis and Identification of Bioactive Compounds of Cannabinoids in Silico for Inhibition of SARS-CoV-2 and SARS-CoV
Chenxiao Chen, Hao Liang, Yanchun Deng, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1729-1729
Open Access | Times Cited: 7
Competitive Inhibition of Okanin against Plasmodium falciparum Tyrosyl-tRNA Synthetase
Guangpu Yang, Yali Liang, Xiang Li, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4751-4751
Open Access | Times Cited: 1
Ocr-mediated suppression of BrxX unveils a phage counter-defense mechanism
Shen Li, Tianhao Xu, Xinru Meng, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 14, pp. 8580-8594
Open Access | Times Cited: 1
Discovery of a small‐molecule inhibitor targeting the ovarian tumor domain of a novel Tamdy orthonairoviruse associated with human febrile illness
Zan Li, Weijia Wang, Yanshuang Xiao, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 12, pp. 5954-5964
Closed Access | Times Cited: 4
Computational and experimental studies of salvianolic acid A targets 3C protease to inhibit enterovirus 71 infection
Sai Shi, Lei Xie, Sen Ma, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Validation of baicalein and oridonin as nonspecific SARS‐CoV‐2 main protease inhibitors
Haohao Yan, Rui Zhang, Gangan Yan, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 3, pp. 1161-1164
Closed Access | Times Cited: 2
Harnessing Natural Products by a Pharmacophore‐Oriented Semisynthesis Approach for the Discovery of Potential Anti‐SARS‐CoV‐2 Agents
Yuan‐Fei Zhou, Bing‐Chao Yan, Qian Yang, et al.
Angewandte Chemie (2022) Vol. 134, Iss. 28
Closed Access | Times Cited: 3
Discovery of the covalent SARS-CoV-2 M pro inhibitors from anti-viral herbs via integrating target-based high-throughput screening and chemoproteomic approaches
Guang‐Bo Ge, Yani Zhang, Guanghao Zhu, et al.
Authorea (Authorea) (2023)
Open Access | Times Cited: 1
Discovery of a Natural Ent-Kaurene Diterpenoid Oridonin as an E3 Ligase Recruiter for PROTACs
Jie Huang, Xuekun Fu, Fang Qiu, et al.
Journal of the American Chemical Society (2024)
Closed Access
Structural biology of SARS-CoV-1/SARS-CoV-2 main protease
Yunyun Gao, Johannes Kaub, Gianluca Santoni, et al.
Crystallography Reviews (2023) Vol. 29, Iss. 2, pp. 76-101
Closed Access
Page 1

Scroll to top